Gheyath Nasrallah

Dr. Gheyath Nasrallah

Department of Biomedical Science, College of Health Sciences, Qatar University
+1
orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
Abdullah A. ShaitoAbdullah A. Shaito
Abdullah A. Shaito
APAnna Maria Posadino
Anna Maria Posadino
NYNadin Younes
Nadin Younes
HHHiba Hasan
Hiba Hasan
SHSarah Halabi
Sarah Halabi
Gianfranco PintusGianfranco Pintus
Gianfranco Pintus
Due to its health benefits, resveratrol (RE) is one of the most researched natural polyphenols. Resveratrol’s health benefits were first highlighted in the early 1990s in the French paradox study, which opened extensive research activity into this compound. Ever since, several pharmacological activities including antioxidant, anti-aging, anti-inflammatory, anti-cancerous, anti-diabetic, cardioprotective, and neuroprotective properties, were attributed to RE. However, results from the available human clinical trials were controversial concerning the protective effects of RE against diseases and their sequelae. The reason for these conflicting findings is varied but differences in the characteristics of the enrolled patients, RE doses used, and duration of RE supplementation were proposed, at least in part, as possible causes. In particular, the optimal RE dosage capable of maximizing its health benefits without raising toxicity issues remains an area of extensive research. In this context, while there is a consistent body of literature on the protective effects of RE against diseases, there are relatively few reports investigating its possible toxicity. Indeed, toxicity and adverse effects were reported following consumption of RE; therefore, extensive future studies on the long-term effects, as well as the in vivo adverse effects, of RE supplementation in humans are needed. Furthermore, data on the interactions of RE when combined with other therapies are still lacking, as well as results related to its absorption and bioavailability in the human body. In this review, we collect and summarize the available literature about RE toxicity and side effects. In this process, we analyze in vitro and in vivo studies that have addressed this stilbenoid. These studies suggest that RE still has an unexplored side. Finally, we discuss the new delivery methods that are being employed to overcome the low bioavailability of RE.

19 August 2019 in Viruses
Verified
Journal Article
Open access
PDF file
MSMaria Smatti
Maria Smatti
FCFarhan Cyprian
Farhan Cyprian
Gheyath NasrallahGheyath Nasrallah
Gheyath Nasrallah
ATAsmaa A. Al Thani
Asmaa A. Al Thani
RARuba O. Almishal
Ruba O. Almishal
HYHADI YASSINE
HADI YASSINE
For a long time, viruses have been shown to modify the clinical picture of several autoimmune diseases, including type 1 diabetes (T1D), systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), Sjögren’s syndrome (SS), herpetic stromal keratitis (HSK), celiac disease (CD), and multiple sclerosis (MS). Best examples of viral infections that have been proposed to modulate the induction and development of autoimmune diseases are the infections with enteric viruses such as Coxsackie B virus (CVB) and rotavirus, as well as influenza A viruses (IAV), and herpesviruses. Other viruses that have been studied in this context include, measles, mumps, and rubella. Epidemiological studies in humans and experimental studies in animal have shown that viral infections can induce or protect from autoimmunopathologies depending on several factors including genetic background, host-elicited immune responses, type of virus strain, viral load, and the onset time of infection. Still, data delineating the clear mechanistic interaction between the virus and the immune system to induce autoreactivity are scarce. Available data indicate that viral-induced autoimmunity can be activated through multiple mechanisms including molecular mimicry, epitope spreading, bystander activation, and immortalization of infected B cells. Contrarily, the protective effects can be achieved via regulatory immune responses which lead to the suppression of autoimmune phenomena. Therefore, a better understanding of the immune-related molecular processes in virus-induced autoimmunity is warranted. Here we provide an overview of the current understanding of viral-induced autoimmunity and the mechanisms that are associated with this phenomenon.

4 January 2022 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Closed access
Hasan SlikaHasan Slika
Hasan Slika
HMHadi Mansour
Hadi Mansour
NWNadine Wehbe
Nadine Wehbe
SNSuzanne Nasser
Suzanne Nasser
RIRabah Iratni
Rabah Iratni
AEAli Eid
Ali Eid

7 April 2020 in Frontiers in Pharmacology
Verified
Journal Article
Open access
PDF file
Abdullah A. ShaitoAbdullah A. Shaito
Abdullah A. Shaito
DTDuong Thi Bich Thuan
Duong Thi Bich Thuan
HPHoa Thi Phu
Hoa Thi Phu
TNThi Hieu Dung Nguyen
Thi Hieu Dung Nguyen
HHHiba Hasan
Hiba Hasan
Gianfranco PintusGianfranco Pintus
Gianfranco Pintus
Cardiovascular diseases (CVDs) are a significant health burden with an ever-increasing prevalence. They remain the leading causes of morbidity and mortality worldwide. The use of medicinal herbs continues to be an alternative treatment approach for several diseases including CVDs. Currently, there is an unprecedented drive for the use of herbal preparations in modern medicinal systems. This drive is powered by several aspects, prime among which are their cost-effective therapeutic promise compared to standard modern therapies and the general belief that they are safe. Nonetheless, the claimed safety of herbal preparations yet remains to be properly tested. Consequently, public awareness should be raised regarding medicinal herbs safety, toxicity, potentially life-threatening adverse effects, and possible herb–drug interactions. Over the years, laboratory data have shown that medicinal herbs may have therapeutic value in CVDs as they can interfere with several CVD risk factors. Accordingly, there have been many attempts to move studies on medicinal herbs from the bench to the bedside, in order to effectively employ herbs in CVD treatments. In this review, we introduce CVDs and their risk factors. Then we overview the use of herbs for disease treatment in general and CVDs in particular. Further, data on the ethnopharmacological therapeutic potentials and medicinal properties against CVDs of four widely used plants, namely Ginseng, Ginkgo biloba, Ganoderma lucidum, and Gynostemma pentaphyllum, are gathered and reviewed. In particular, the employment of these four plants in the context of CVDs, such as myocardial infarction, hypertension, peripheral vascular diseases, coronary heart disease, cardiomyopathies, and dyslipidemias has been reviewed, analyzed, and critically discussed. We also endeavor to document the recent studies aimed to dissect the cellular and molecular cardio-protective mechanisms of the four plants, using recently reported in vitro and in vivo studies. Finally, we reviewed and reported the results of the recent clinical trials that have been conducted using these four medicinal herbs with special emphasis on their efficacy, safety, and toxicity.

2 November 2021 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
PTPatrick Tang
Patrick Tang
MHMohammad R. Hasan
Mohammad R. Hasan
HCHiam Chemaitelly
Hiam Chemaitelly
HYHADI YASSINE
HADI YASSINE
FBFatiha Benslimane
Fatiha Benslimane
Laith Abu-RaddadLaith Abu-Raddad
Laith Abu-Raddad

9 July 2021 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
HCHiam Chemaitelly
Hiam Chemaitelly
HYHADI YASSINE
HADI YASSINE
FBFatiha M. Benslimane
Fatiha M. Benslimane
HKHebah A. Al Khatib
Hebah A. Al Khatib
PTPatrick Tang
Patrick Tang
Laith Abu-RaddadLaith Abu-Raddad
Laith Abu-Raddad